Author:
Dessens Femke M.,Steenvoorden Daniëlle,van Oijen Marieke,Biermasz Nienke R.,Goossens-Laan Catharina A.
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Davis A, Goel S, Picolos M, Wang M, Lavis V. Pituitary apoplexy after leuprolide. Pituitary. 2006;9:263–5.
2. Huang T, Lin J, Lieu A, Chen Y, Chen H, Jang M, et al. Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case. World J Surg Oncol. 2013;11:254–8.
3. Sasagawa Y, Tachibana O, Nakagawa A, Koya D, Lizuka H. Pituitary apoplexy following gonadotropin-releasing hormone agonist administration with gonadotropin-secreting pituitary adenoma. J Clin Neurosci. 2015;22:601–3.
4. Blaut K, Wisniewski P, Syrenicz A, Sworczak K. Apoplexy of clinically silent pituitary adenoma during prostate cancer treatment with LHRH analog. Neuro Endocrinol Lett. 2006;27:569–72.
5. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf). 1999;51:181–8.